Literature DB >> 27813244

Percutaneous PDA Closure in Extremely Low Birth Weight Babies.

Nazmi Narin1, Ozge Pamukcu1, Ali Baykan1, Suleyman Sunkak1, Ayse Ulgey2, Kazim Uzum1.   

Abstract

AIM: Patent Ductus Arteriosus is an important cause of morbidity and mortality in preterms. As birth weight decrease, risks increase. Main aim of our study is to emphasize the effectiveness and safety of percutaneous PDA closure even in extremely low birth infants.
MATERIALS AND METHODS: In our center between the dates June 2014-June 2016, PDA of 10 patients less than 1,000 gr were closed percutaneously. To the best of our knowledge this study includes the largest cohort of infants less than 1,000 g in the literature, that PDA of those were percutaneously closed.
RESULTS: Symptomatic patients, less than 1,000 gr having PDA were included in the study. All have 3 times medical therapy for PDA closure but it did not work. PDA was decided to be contributor of this medical state of them. The mean patient age was 19.5 ± 7.2 days. The median weight was 950 (842-983) gr. Mean gestational age was: 26.3 ± 0.63 weeks. Mean PDA diameter was 1.9 ± 0.41 mm. Morphology of PDA:6 of them were conical and 4 of them were tubular. In all patients ADOII-AS device were used for PDA closure via venous route. No major complications were reported. Left pulmonary arterial stenosis was detected in 1 patient who was resolved in 6 months duration.
CONCLUSION: We want to emphasize that in experienced centers percutaneous closure of PDA can be an alternative to surgery even in the extremely low birth weight babies.
© 2016, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27813244     DOI: 10.1111/joic.12352

Source DB:  PubMed          Journal:  J Interv Cardiol        ISSN: 0896-4327            Impact factor:   2.279


  5 in total

Review 1.  Percutaneous Closure of Patent Ductus Arteriosus.

Authors:  Megan Barcroft; Christopher McKee; Darren P Berman; Rachel A Taylor; Brian K Rivera; Charles V Smith; Jonathan L Slaughter; Afif El-Khuffash; Carl H Backes
Journal:  Clin Perinatol       Date:  2022-01-21       Impact factor: 3.430

2.  Institutional Trend in Device Selection for Transcatheter PDA Closure in Premature Infants.

Authors:  Peter Guyon; Nicole Duster; Anup Katheria; Caitlyn Heyden; Danica Griffin; Ronald Steinbergs; Andres Moreno Rojas; Kanishka Ratnayaka; Howaida G El-Said
Journal:  Pediatr Cardiol       Date:  2022-04-16       Impact factor: 1.838

3.  Surgical Ligation Versus Percutaneous Closure of Patent Ductus Arteriosus in Very Low-Weight Preterm Infants: Which are the Real Benefits of the Percutaneous Approach?

Authors:  A Rodríguez Ogando; I Planelles Asensio; A Rodríguez Sánchez de la Blanca; F Ballesteros Tejerizo; M Sánchez Luna; J M Gil Jaurena; C Medrano López; J L Zunzunegui Martínez
Journal:  Pediatr Cardiol       Date:  2017-11-08       Impact factor: 1.655

4.  Transcatheter Closure of Arterial Duct in Infants < 6 kg: Amplatzer Duct Occluder Type I vs Amplatzer Duct Occluder II Additional Sizes.

Authors:  Giuseppe Santoro; Mario Giordano; Gianpiero Gaio; Maria Teresa Palladino; Giovanbattista Capozzi; Carola Iacono; Maria Giovanna Russo
Journal:  Pediatr Cardiol       Date:  2018-02-17       Impact factor: 1.655

5.  Percutaneous Closure of Ductus Arteriosus in Preterm Babies: The Initial Brazilian Experience.

Authors:  João Luiz Langer Manica; Juliana Rodrigues Neves; Raul Arrieta; Pedro Abujamra; Raul Ivo Rossi Filho; Luiz Carlos Giuliano; Germana Coimbra; Pablo Tomé Teixeirense; João Henrique Aramayo Rossi; Rodrigo Nieckel da Costa; Salvador André Bavaresco Cristóvão; Carlos Pedra
Journal:  Arq Bras Cardiol       Date:  2022-09       Impact factor: 2.667

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.